NCT00668070View on ClinicalTrials.gov

A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831

PHASE2CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Non-Alcoholic Steatohepatitis
Interventions
DRUG

ASP9831

Oral

DRUG

Placebo

Oral

Trial Locations (30)

1200

Brussels

2650

Antwerp

3000

Leuven

3010

Bern

4031

Basel

7100

La Louvière

8091

Zurich

9000

Ghent

13353

Berlin

14021

Prague

18000

Prague

33604

Pessac

34295

Montpellier

45122

Essen

49933

Angers

55101

Mainz

60590

Frankfurt am Main

62500

Brno-Bohunice

75571

Paris

75651

Paris

93042

Regensburg

300736

Timișoara

700111

Iași

Unknown

Amiens

Birmingham

London

021105

Bucharest

022328

Bucharest

NE77DN

Newcastle upon Tyne

NG77DN

Nottingham

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY